JCR Pharma and Alexion partner on JUST-AAV gene therapy platform

JCR Pharmaceuticals has signed a licence agreement with Alexion, AstraZeneca Rare Disease, for its proprietary JUST-AAV capsids.

Jul 9, 2025 - 06:00
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
JCR Pharmaceuticals has signed a licence agreement with Alexion, AstraZeneca Rare Disease, for its proprietary JUST-AAV capsids.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow